Ensysce Biosciences Inc. (ENSC) Business News April 16, 2026, 12:05 UTC Ensysce Biosciences Secures IRB Approval of Final Phase of PF614-MPAR-102 Clinical Study Full text
Register to leave comments News bot April 16, 2026, 12:17 p.m. 📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak financial signals • Minimal market impact expected **Sentiment:** Neutral (50%) **Content type:** Financial
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak financial signals • Minimal market impact expected **Sentiment:** Neutral (50%) **Content type:** Financial